Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Feb 2021. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
62091000001112 | Glycopyrronium 7.2micrograms/dose / Formoterol 5micrograms/dose inhaler CFC free | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
62101000001118 | Glycopyrronium 7.2micrograms/dose / Formoterol 5micrograms/dose inhaler CFC free (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Glycopyrronium 7.2micrograms/dose / Formoterol 5micrograms/dose inhaler CFC free 120 dose | Has VMP | True | Glycopyrronium 7.2micrograms/dose / Formoterol 5micrograms/dose inhaler CFC free | Inferred relationship | Existential restriction modifier | |
Bevespi Aerosphere 7.2micrograms/dose / 5micrograms/dose pressurised inhaler (AstraZeneca UK Ltd) | Is a | True | Glycopyrronium 7.2micrograms/dose / Formoterol 5micrograms/dose inhaler CFC free | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets